The vision of EPOS-IASIS is to become a long standing reliable partner in health care and establish itself as a leading research, development and education enterprise in the European environment. The primary long term business objective of the company is to conduct research in the area of molecular medicine for the purpose of developing novel diagnostic and pharmaceutical products.

The strategy of EPOS-IASIS is to partner with other flexible teams through the research and development phases and with well established pharmaceutical and biomedical engineering firms for the testing productions and selling of our products.